Medication info
HILUSMET Tablets

HILUSMET Tablets

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea United Pharm, Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP X3)]
Approval status
Active

MFDS item code 202106959 · Approved 2021.10.18 · Insurance code 644309660

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, within the limits of 100mg vildagliptin and 2000mg metformin. Doses of vildagliptin greater than 100mg daily are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous experience of antidiabetic drug therapy for whom adequate glycemic control cannot be achieved with monotherapy: The initial dose is 50/500mg, 1 tablet once daily. The dose may be increased gradually up to 50/1000mg, 1 tablet twice daily. 2. Patients switching from concomitant vildagliptin and metformin therapy: Patients switching from concomitant vildagliptin and metformin therapy to this medicine may start at their previous doses of vildagliptin and metformin. No studies have evaluated the safety and efficacy of switching from other oral antihyperglycemic agents to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may alter glycemic control; therefore, caution and appropriate monitoring are required. If you miss a dose of this medicine, take it with your next meal unless it is time to take the next dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment with this medicine.

Ingredients

Manufacturer
Korea United Pharm, Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes by combining vildagliptin and metformin. It is more effective when taken along with dietary therapy and exercise. This helps stabilize the patient's blood sugar levels and improves diabetes management.

How to take

Adult dose

For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, within the limits of 100mg vildagliptin and 2000mg metformin. Doses of vildagliptin greater than 100mg daily are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous experience of antidiabetic drug therapy for whom adequate glycemic control cannot be achieved with monotherapy: The initial dose is 50/500mg, 1 tablet once daily. The dose may be increased gradually up to 50/1000mg, 1 tablet twice daily. 2. Patients switching from concomitant vildagliptin and metformin therapy: Patients switching from concomitant vildagliptin and metformin therapy to this medicine may start at their previous doses of vildagliptin and metformin. No studies have evaluated the safety and efficacy of switching from other oral antihyperglycemic agents to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may alter glycemic control; therefore, caution and appropriate monitoring are required. If you miss a dose of this medicine, take it with your next meal unless it is time to take the next dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment with this medicine.

Precautions

This medication should be used with great caution as it can cause severe lactic acidosis or hypoglycemia. It should not be used in patients with moderate to severe renal impairment, heart failure, acute heart disease, or sepsis. Prior to examinations using radiological iodine contrast agents, this medication should be discontinued at least 48 hours in advance, and it should only be resumed after confirming normal kidney function. It should not be administered to patients with hypersensitivity to this medication or those with type 1 diabetes or diabetic ketoacidosis. If a patient has severe infections, serious trauma, during and after surgery, malnutrition, liver dysfunction, pulmonary dysfunction, excessive alcohol consumption, etc., the use of this medication should be temporarily halted and resumed only once the condition improves. It is advisable to avoid using this medication in pregnant or nursing women. This medication should be used carefully in cases of irregular meals, intense exercise, or interactions with other medications, and patients with allergies to certain dyes should be cautious. During treatment, liver and kidney functions must be regularly checked to ensure there are no abnormalities; if hepatic impairment is detected, discontinue use. Due to the risk of lactic acidosis, if dehydration, hypoxemia, severe diarrhea, or vomiting occurs, the use of this medication should be stopped immediately and a physician should be consulted. Alcohol may increase the risk of side effects from this medication, thus it should be avoided while taking it. Hypoglycemic symptoms may occur, so blood sugar levels should be closely monitored, especially when taken with other hypoglycemic agents. This medication is not recommended for children under 18 years old, and dosage adjustment may be necessary for elderly patients depending on renal function. In case of overdose, blood dialysis may be required, and immediate medical attention should be sought. If any abnormal skin symptoms such as blisters or ulcers develop while taking this medication, consult a doctor immediately. Caution should be taken as dizziness or drowsiness may occur when driving or operating machinery.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • hepatitis
  • impaired liver function
  • elevated transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
Show 50 more
  • nausea
  • hypoglycemia
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • reduced blood sugar
  • weakness
  • sweating
  • constipation
  • arthralgia
  • upper respiratory tract infection
  • nasopharyngitis
  • peripheral edema
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • taste disorders
  • erythema
  • itching
  • urticaria
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe and disabling arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • dyspepsia
  • abdominal discomfort
  • gastrointestinal abnormalities
  • increased serum amylase
  • increased lipase
  • vesicular pemphigoid
  • myalgia
  • paraesthesia
  • fever
  • edema
  • swelling of hands and feet
  • elevated creatine phosphokinase
  • elevated AST
  • elevated C-reactive protein
  • elevated myoglobin levels
  • skin lesions
  • skin peeling
  • crusts
  • tail inflammation
  • necrotizing lesions of the tail

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and humidity, thus it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees. This helps preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP X3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.